基于影像学模型预测胰腺导管内乳头状黏液性肿瘤恶性潜能
本研究回顾性分析241例IPMN患者术前CT和MRI,开发并验证基于影像特征的恶性风险预测模型(连续变量模型C和二分变量模型D),并与国际指南模型F比较。模型C在CT上识别年龄、壁结节大小、主胰管直径和淋巴结病为独立预测因子,MRI上识别年龄和壁结节存在及大小为独立预测因子;模型C的AUC为0.763-0.899,与模型F(AUC 0.729-0.952)无显著差异。结论认为基于影像的模型能有效预测IPMN恶性风险,与国际共识指南相当。
要点
- 基于CT的模型C独立预测因子包括年龄、壁结节大小、主胰管直径和淋巴结病。
- 基于MRI的模型C独立预测因子包括年龄以及壁结节的存在和大小。
- 模型C的AUC为0.763-0.899,与指南模型F(AUC 0.729-0.952)无显著差异。
核心结论
- 基于影像的模型能有效预测IPMN恶性风险,性能与国际共识指南相当。
研究设计与样本
- 回顾性分析241例IPMN患者术前CT和MRI用于模型开发,内部验证集55例,外部验证集43例,参考标准为病理恶性诊断,比较模型C、模型D与指南模型F。
关键影像表现/征象
- 评估的影像特征包括囊肿大小、强化壁结节的存在和大小、主胰管直径、囊壁增厚/强化、主胰管管径突然变化伴远端萎缩以及淋巴结病。
诊断标准与关键数值
- 模型C(连续变量)在CT上的独立预测因子为年龄、壁结节大小、主胰管直径和淋巴结病,在MRI上为年龄以及壁结节的存在和大小。
- 模型D(二分变量)在CT上的独立预测因子为年龄≥68岁、囊肿大小≥31 mm、壁结节≥6 mm、主胰管≥7 mm和淋巴结病,在MRI上为年龄≥68岁、壁结节≥4.5 mm和淋巴结病。
- 模型C的AUC为0.763-0.899,模型D的AUC为0.753-0.912,两者无统计学显著差异。
- 模型C与模型F(AUC 0.729-0.952)无显著差异。
- 模型C联合梗阻性黄疸后AUC为0.802-0.941,但无统计学显著改善。
临床应用与阅片要点
- 影像特征对预测IPMN恶性潜能具有重要价值。
- 基于影像的模型可能有助于确定IPMN患者的手术候选资格。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and validate imaging-based models for predicting the malignancy risk of intraductal papillary mucinous neoplasm (IPMN).
MATERIALS AND METHODS: We retrospectively analyzed data from 241 IPMN patients who underwent preoperative CT and MRI for model development. Cyst size, presence and size of the enhancing mural nodule (EMN), main pancreatic duct (MPD) diameter, thickened/enhancing cyst wall, abrupt MPD caliber change with distal atrophy, and lymphadenopathy were assessed. Multiple logistic regression models predicting malignancy risk were created using either continuous (Model C) or dichotomized variables (Model D) using these imaging features. Validation included internal (n = 55) and external (n = 43) datasets. Model performance was assessed using the area under the receiver operating characteristic curve (AUC) and compared with that of the international guideline-based model (Model F).
RESULTS: Model C identified age, EMN size, MPD diameter, and lymphadenopathy as independent predictors on CT, and age and presence and size of EMN on MRI. Model D identified age ≥ 68, cyst size ≥ 31 mm, EMN ≥ 6 mm, MPD ≥ 7 mm, and lymphadenopathy as independent predictors on CT, and age ≥ 68, EMN ≥ 4.5 mm, and lymphadenopathy on MRI. Model C (AUC, 0.763-0.899) performed slightly better than Model D (AUC, 0.753-0.912) without statistical significance. No significant difference was observed between Models C and F (AUC, 0.729-0.952). Combining Model C with obstructive jaundice improved performance (AUC, 0.802-0.941) without statistical significance.
CONCLUSION: Our imaging-based models effectively predicted the malignancy risk of IPMNs, comparable to international consensus guidelines.
CLINICAL RELEVANCE STATEMENT: Imaging features are important for predicting the malignant potential of IPMNs. Our imaging-based model may help determine surgical candidacy for patients with IPMNs.
KEY POINTS: Non-invasively determining the malignant potential of intraductal papillary mucinous neoplasms (IPMNs) allows for appropriate treatment decision-making We identified multiple imaging features that are associated with malignant transformation and developed models for this prediction. Our model performs comparably with international consensus guidelines in predicting the malignant potential of IPMNs.
引用
- Park J, Kim JH, Bae JS, et al. An imaging-based model to predict the malignant potential of intraductal papillary mucinous neoplasm of the pancreas. Eur Radiol. 2024. PMID: 39112752. doi:10.1007/s00330-024-11003-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。